Diagnosing epilepsy to help guide treatment
Part of Brain & nervous system clinical trials.
This trial tests a new device to help diagnose epilepsy in people whose previous EEG brain monitoring did not give clear answers. If you have drug-resistant epilepsy with at least one seizure a month on average, this study may help find better treatment options.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with focal or generalized epilepsy
- Your seizures are not controlled by medication
- You have had at least 1 seizure per month on average in the last 3 months
- You had a multi-day brain wave test (EEG) that did not give clear results, and your condition hasn't changed since then
- You have not had epilepsy surgery in the last 6 months
- You do not have an active brain stimulation device like DBS or RNS
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people who previously enrolled in the DETECT study and had a Minder device implanted to monitor brain activity. The goal is to see how the device performs over a longer period of time.
This study tests a new type of EEG (brain wave) sensor placed under the scalp to see if it can accurately record seizure signals during the standard monitoring you're already scheduled for. If it works well, it could lead to a less invasive way to monitor epilepsy in the future.
This trial tests a non-invasive brain stimulation technique during routine epilepsy monitoring to see if it can help reduce seizures. It may offer a new way to manage epilepsy without surgery.
This trial tests if tracking your brain activity with an implanted device can help predict when seizures might happen. It is for adults who have seizures despite medication and already have the RNS System implanted.
This study tests a new MEG (magnetoencephalography) device, which is a safe, non-invasive brain scan that measures magnetic fields from brain activity. The goal is to see if it can help doctors find the exact spot causing seizures, which could improve surgery planning for people with drug-resistant epilepsy.
This study tests a new “hybrid” type of electrodes placed inside the brain to better map where seizures start in people with difficult (drug-resistant) focal epilepsy. It may help doctors plan safer and more effective surgery, though it involves an invasive brain monitoring procedure.
Hear when a new Epilepsy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.